Skip to main content
Veterinary Medicines

VERSIFEL CVR, liofilizat i diluent za suspenziju za injekciju, za mačke

Authorised
  • Feline calicivirus, strain F9, Live
  • Felid herpesvirus 1, strain FVRm, Live
  • Feline panleucopenia virus, strain Snow Leopard, Live

Product identification

Medicine name:
VERSIFEL CVR, liofilizat i diluent za suspenziju za injekciju, za mačke
Active substance:
  • Feline calicivirus, strain F9, Live
  • Felid herpesvirus 1, strain FVRm, Live
  • Feline panleucopenia virus, strain Snow Leopard, Live
Target species:
  • Cat
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Feline calicivirus, strain F9, Live
    10000.00
    cell culture infective dose 50
    /
    1.00
    millilitre(s)
  • Felid herpesvirus 1, strain FVRm, Live
    100000.00
    cell culture infective dose 50
    /
    1.00
    millilitre(s)
  • Feline panleucopenia virus, strain Snow Leopard, Live
    1000.00
    cell culture infective dose 50
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Lyophilisate and solvent for suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI06AD04
Authorisation status:
  • Valid
Authorised in:
  • Croatia
Available in:
  • Croatia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Zoetis B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bioveta a.s.
Responsible authority:
  • Ministry Of Agriculture Veterinary And Food Safety Directorate
Authorisation number:
  • UP/I-322-05/18-01/614
Date of authorisation status change:
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."